{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T14:08:02Z","timestamp":1794751682721,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ygyno.2021.09.016","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T12:05:29Z","timestamp":1633003529000},"page":"531-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement"],"prefix":"10.1016","volume":"163","author":[{"given":"Yvonne M.","family":"Hoeijmakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalck K.","family":"Eysbouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Dandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Inthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.E.","family":"van Trommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petronella B.","family":"Ottevanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M.G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.G.J.","family":"Sweep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2021.09.016_bb0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"16","key":"10.1016\/j.ygyno.2021.09.016_bb0010","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","article-title":"Clinical practice. Molar pregnancy","volume":"360","author":"Berkowitz","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ygyno.2021.09.016_bb0015","first-page":"591","article-title":"Predictors of persistent disease in women with complete hydatidiform mole","volume":"41","author":"Ayhan","year":"1996","journal-title":"J. Reproduct. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.016_bb0020","first-page":"285","article-title":"FIGO oncology committee","volume":"77","author":"FIGO staging for gestational trophoblastic neoplasia","year":"2000","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"11","key":"10.1016\/j.ygyno.2021.09.016_bb0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s11912-014-0408-y","article-title":"Gestational trophoblastic tumours: an update for 2014","volume":"16","author":"Froeling","year":"2014","journal-title":"Curr. Oncol. Rep."},{"issue":"9 Suppl 3","key":"10.1016\/j.ygyno.2021.09.016_bb0030","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/IGC.0000000000000294","article-title":"Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup","volume":"24","author":"Mangili","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.016_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2016.08.330","article-title":"15years of progress in gestational trophoblastic disease: scoring, standardization, and salvage","volume":"144","author":"Brown","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.016_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1525-1438.2007.00993.x","article-title":"Early identification of persistent trophoblastic disease with serum hCG concentration ratios","volume":"18","author":"van Trommel","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2021.09.016_bb0045","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.2002.07.166","article-title":"Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000","volume":"20","author":"McNeish","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.016_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ygyno.2004.11.011","article-title":"Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy","volume":"96","author":"Matsui","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.09.016_bb0055","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/IGC.0000000000001248","article-title":"Efficacy and safety of second-line 5-day dactinomycin in case of methotrexate failure for gestational trophoblastic neoplasia","volume":"28","author":"Prouvot","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7\u20138","key":"10.1016\/j.ygyno.2021.09.016_bb0060","first-page":"283","article-title":"Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia","volume":"57","author":"Lurain","year":"2012","journal-title":"J. Reproduct. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.016_bb0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ygyno.2016.10.001","article-title":"Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia","volume":"143","author":"Winter","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.09.016_bb0070","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/IGC.0000000000000966","article-title":"Serum human chorionic gonadotropin Normogram for the detection of gestational trophoblastic neoplasia","volume":"27","author":"Eysbouts","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.016_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.2005.03.3043","article-title":"Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease","volume":"24","author":"van Trommel","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.09.016_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/gyno.1998.5210","article-title":"Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles","volume":"71","author":"Shigematsu","year":"1998","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.016_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2011.10.003","article-title":"Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study","volume":"160","author":"Kim","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.016_bb0090","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjc.6604849","article-title":"External validation of serum hCG cutoff levels for prediction of resistance to single-agent chemotherapy in patients with persistent trophoblastic disease","volume":"100","author":"Kerkmeijer","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.016_bb0095","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IGC.0b013e31829703ea","article-title":"Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia","volume":"23","author":"Lybol","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.016_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-8258(88)90150-3","article-title":"Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia","volume":"29","author":"Rotmensch","year":"1988","journal-title":"Gynecol. Oncol."},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2021.09.016_bb0105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9378(12)90820-0","article-title":"Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve","volume":"168","author":"Yedema","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.016_bb0110","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/IGC.0000000000000812","article-title":"Dutch risk classification and FIGO 2000 for gestational trophoblastic neoplasia compared","volume":"26","author":"Eysbouts","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.09.016_bb0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2020.02.011","article-title":"Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease","volume":"130","author":"Lok","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"Pt 3","key":"10.1016\/j.ygyno.2021.09.016_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/000456328502200305","article-title":"Comparison of the analytical characteristics and clinical usefulness in tumour monitoring of fifteen hCG(\u2212beta) immunoassay kits","volume":"22","author":"Thomas","year":"1985","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ygyno.2021.09.016_bb0125","series-title":"R: A language and Environment for Statistical Computing","author":"Core Team","year":"2019"},{"key":"10.1016\/j.ygyno.2021.09.016_bb0130","series-title":"Regression Modeling Strategies: Documentation for Package \u2018rms\u2019 Version 5.0\u20130","author":"Harrell","year":"2016"},{"issue":"1","key":"10.1016\/j.ygyno.2021.09.016_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiol. (Cambridge, Mass)"},{"issue":"11","key":"10.1016\/j.ygyno.2021.09.016_bb0140","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/oxfordjournals.aje.a009592","article-title":"Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test","volume":"148","author":"Choi","year":"1998","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.016_bb0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thoracic Oncol."},{"key":"10.1016\/j.ygyno.2021.09.016_bb0150","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2016"},{"key":"10.1016\/j.ygyno.2021.09.016_bb0155","first-page":"Cd007102","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"6","author":"Lawrie","year":"2016","journal-title":"The Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.ygyno.2021.09.016_bb0160","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.09.016_bb0165","first-page":"907","article-title":"Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine general hospital: treatment outcomes and toxicity","volume":"51","author":"Cagayan","year":"2006","journal-title":"J. Reproduct. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.016_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3349\/ymj.1996.37.6.412","article-title":"Analysis of risk factors for postmolar trophoblastic disease: categorization of risk factors and effect of prophylactic chemotherapy","volume":"37","author":"Park","year":"1996","journal-title":"Yonsei Med. J."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.016_bb0175","first-page":"Cd007289","article-title":"Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia","volume":"9","author":"Wang","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.ygyno.2021.09.016_bb0180","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/cncr.22118","article-title":"Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study","volume":"107","author":"Covens","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.016_bb0185","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/1471-0528.16198","article-title":"Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study","volume":"127","author":"Hoeijmakers","year":"2020","journal-title":"Bjog"},{"issue":"Suppl. 6","key":"10.1016\/j.ygyno.2021.09.016_bb0190","article-title":"Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Seckl","year":"2013","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.016_bb0195","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ygyno.2011.10.035","article-title":"Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole","volume":"124","author":"Kang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.09.016_bb0200","doi-asserted-by":"crossref","first-page":"494695","DOI":"10.1155\/2014\/494695","article-title":"Does postevacuation beta -human chorionic gonadotropin level predict the persistent gestational trophoblastic neoplasia?","volume":"2014","author":"Mousavi","year":"2014","journal-title":"ISRN Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2021.09.016_bb0205","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/bimj.201900044","article-title":"A tutorial on dynamic risk prediction of a binary outcome based on a longitudinal biomarker","volume":"62","author":"Dandis","year":"2020","journal-title":"Biom. J."},{"issue":"9","key":"10.1016\/j.ygyno.2021.09.016_bb0210","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2013.123","article-title":"Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements","volume":"108","author":"You","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.09.016_bb0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.1.01997","article-title":"Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios","volume":"153","author":"van Trommel","year":"2005","journal-title":"Eur. J. Endocrinol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:58:23Z","timestamp":1758772703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0090825821013858"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.016","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}